- Honda and Nissan expected to begin merger talks
- 'Draconian' Vietnam internet law heightens free speech fears
- Israeli women mobilise against ultra-Orthodox military exemptions
- Asian markets track Wall St rally as US inflation eases rate worries
- Tens of thousands protest in Serbian capital over fatal train station accident
- Trump vows to 'stop transgender lunacy' as a top priority
- Daniels throws five TDs as Commanders down Eagles, Lions and Vikings win
- 'Who's next?': Misinformation and online threats after US CEO slaying
- Only 12 trucks delivered food, water in North Gaza Governorate since October: Oxfam
- Langers edge Tiger and son Charlie in PNC Championship playoff
- Explosive batsman Jacobs gets New Zealand call-up for Sri Lanka series
- Holders PSG edge through on penalties in French Cup
- Slovak PM Fico on surprise visit to Kremlin to talk gas deliveries
- Daniels throw five TDs as Commanders down Eagles
- Atalanta fight back to take top spot in Serie A, Roma hit five
- Mancini admits regrets over leaving Italy for Saudi Arabia
- Run machine Ayub shines as Pakistan sweep South Africa
- Slovak PM Fico on surprise visit to Kremlin
- Gaza rescuers say Israeli strikes kill 35
- 'Incredible' Liverpool must stay focused: Slot
- Maresca 'absolutely happy' as title-chasing Chelsea drop points in Everton draw
- Salah happy wherever career ends after inspiring Liverpool rout
- Three and easy as Dortmund move into Bundesliga top six
- Liverpool hit Spurs for six, Man Utd embarrassed by Bournemouth
- Netanyahu vows to act with 'force, determination' against Yemen's Huthis
- Mbappe back from 'bottom' as Real Madrid down Sevilla
- Ali hat-trick helps champions Ahly crush Belouizdad
- France kept on tenterhooks over new government
- Salah stars as rampant Liverpool hit Spurs for six
- Syria's new leader says all weapons to come under 'state control'
- 'Sonic 3' zips to top of N.America box office
- Rome's Trevi Fountain reopens to limited crowds
- Mbappe strikes as Real Madrid down Sevilla
- 'Nervous' Man Utd humiliated by Bournemouth
- Pope again condemns 'cruelty' of Israeli strikes on Gaza
- Lonely this Christmas: Vendee skippers in low-key celebrations on high seas
- Troubled Man Utd humiliated by Bournemouth
- 2 US pilots shot down over Red Sea in 'friendly fire' incident: military
- Man Utd embarrassed by Bournemouth, Chelsea held at Everton
- France awaits fourth government of the year
- Germany pledges security inquest into Christmas market attack
- Death toll in Brazil bus crash rises to 41
- Joshua bout only fight left for beaten Fury says promoter Hearn
- Odermatt stays hot to break Swiss World Cup wins record
- Neville says Rashford's career at Man Utd nearing 'inevitable ending'
- Syria's new leader vows not to negatively interfere in Lebanon
- Germany pledges security inquest after Christmas market attack
- Putin vows 'destruction' on Ukraine after Kazan drone attack
- Understated Usyk seeks recognition among boxing legends
- France awaits appointment of new government
Indica Labs Joins the AWS Partner Network
Indica Labs, the global leader in AI-powered digital pathology software and services, announced today that they have joined the Amazon Web Services (AWS) Partner Network (APN). The APN is a global community of AWS Partners that leverage programs, expertise, and resources to build, market, and co-sell customer offerings. With the successful completion of the foundational technical review of HALO®, HALO AI, HALO Link, and HALO AP®, these platforms are now AWS Qualified Software. Customers now have confidence that the cloud architecture utilized by Cloud Services for life sciences and clinical deployments is validated by AWS.
"Indica Labs is honored to join the APN," said Eric Runde, Chief Operating Officer, Indica Labs. "AWS has long been recognized as the leading cloud services provider and it is an honor to meet their rigid standards and bring their technical advantages to customers of Indica Labs."
In addition to confidence in the security, performance, and scalability of HALO deployments, an optimized cloud deployment can lead to significant cost savings for customers. In a recent Cloud Services deployment of HALO®, HALO AI, and HALO Link software at the University of Washington BioRepository and Integrated Neuropathology (BRaIN) laboratory, a Cloud Services managed AWS deployment led to a 40% reduction in AWS cost in four months. Dr. C. Dirk Keene, Professor, University of Washington Department of Laboratory Medicine and Pathology Leader, commented, "Moving our HALO deployments to the cloud with Cloud Services has decreased monthly costs substantially and has allowed us to easily collaborate with other research institutions across the country."
The Cloud Services team is comprised of AWS Certified Solution Architects who have deep subject matter expertise in HALO deployments and are experienced with performing data migrations and facilitating custom integrations. Cloud Services customers maintain full ownership over their AWS account while Cloud Services manages all technical aspects of implementation and ongoing maintenance to deliver a highly performant and scalable HALO environment.
As an APN member, Indica Labs joins a global network of 130,000 Partners from more than 200 countries working with AWS to provide innovative solutions, solve technical challenges, win deals, and deliver value to mutual customers.
For more information, visit https://indicalab.com/cloud-services/ and https://aws.amazon.com/partners/.
HALO AP® is CE-IVDR marked for in-vitro diagnostic use in Europe, the UK, and Switzerland. HALO AP® is For Research Use Only in the USA and is not FDA cleared for clinical diagnostic use. In addition, HALO AP® provides built-in compliance with FDA 21 CFR Part 11, HIPAA, and GDPR.
About Indica Labs: Indica Labs is the global leader in AI-powered digital pathology software and services. Our flagship HALO® and HALO AI platform revolutionizes quantitative evaluation of whole slide images. HALO Link provides collaborative image management while HALO AP® and HALO AP Dx deliver enterprise digital pathology for primary diagnosis with regulatory clearances in multiple markets. Through a commitment to open pathology, performance, scalability, and ease-of-use, we help pharma companies, diagnostic labs, hospitals, research organizations, and Indica's own Cloud and Pharma Services make discoveries and diagnoses that transform patient care and scientific discovery.
Media Contact:
Eric Runde
[email protected]
SOURCE: Indica Labs
F.Pedersen--AMWN